ARCHIVES

FDA Approves Erbitux for Head & Neck Cancer.

This article is from The Cancer Letter archive.

Vol. 32 No. 08 | March 3, 2006

Download PDF Visit The Full Archive

Related Articles

Saffiotti Quits As Carcinogenesis Chief With Blast At Rauscher, Peters

April 30, 1976

NCAB to Review Coding of Projects Addressing Minorites and Undeserved

February 19, 1999

At Least 25 CCOP Applicants Score High Enough To Virtually Assure Funding; Geography An Issue

May 13, 1983

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002

Top Management Shifts At Bristol-Myers Squibb Oncology, R&D Units

October 6, 1995

In Congress: Human Genome Project Ahead Of Schedule, Collins Assert

March 27, 1998